Neurocrine Bioscienc (NBIX)
106.03 -0.70 (-0.66%) 13:06 ET [NASDAQ]
105.90 x 2 106.14 x 248
Realtime by (Cboe BZX)
105.90 x 2 106.14 x 248
Realtime 107.14 +0.41 (+0.38%) 09:30 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 341,300 | 249,700 | 154,500 | 89,600 | 407,300 |
| Depreciation Amortization | 900 | 3,000 | 19,300 | 35,600 | 30,000 |
| Income taxes - deferred | -123,100 | -56,700 | 19,100 | 4,300 | -310,700 |
| Accounts receivable | -39,800 | -89,300 | -162,200 | -28,400 | -30,500 |
| Other Working Capital | -19,200 | 28,200 | -67,400 | 16,700 | -37,900 |
| Other Operating Activity | 435,300 | 255,000 | 376,100 | 138,700 | 170,300 |
| Operating Cash Flow | $595,400 | $389,900 | $339,400 | $256,500 | $228,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,056,100 | -1,379,900 | -621,200 | -102,200 | -735,500 |
| PPE Investments | -38,200 | -28,300 | -16,500 | -23,400 | -10,900 |
| Net Acquisitions | N/A | N/A | -42,700 | N/A | N/A |
| Purchase Of Investment | N/A | -31,300 | -7,700 | -4,600 | N/A |
| Sale Of Investment | 967,500 | 972,400 | 511,000 | N/A | 750,500 |
| Investing Cash Flow | $-126,800 | $-467,100 | $-177,100 | $-130,200 | $4,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -186,900 |
| Debt Repayment | -308,800 | N/A | -279,000 | -100 | N/A |
| Common Stock Issued | 122,100 | 65,300 | 44,700 | 27,500 | 29,100 |
| Common Stock Repurchased | -300,000 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $-486,700 | $65,300 | $-234,300 | $27,400 | $-157,800 |
| Exchange Rate Effect | 0 | 300 | -1,300 | N/A | N/A |
| Beginning Cash Position | 259,100 | 270,700 | 344,000 | 190,300 | 115,500 |
| End Cash Position | 241,000 | 259,100 | 270,700 | 344,000 | 190,300 |
| Net Cash Flow | $-18,100 | $-11,600 | $-73,300 | $153,700 | $74,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 595,400 | 389,900 | 339,400 | 256,500 | 228,500 |
| Capital Expenditure | -38,200 | -28,300 | -16,500 | -23,400 | -10,900 |
| Free Cash Flow | 557,200 | 361,600 | 322,900 | 233,100 | 217,600 |